Cover Image
市場調查報告書

巨細胞動脈炎:全球臨床實驗檢討

Giant Cell Arteritis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 312393
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
巨細胞動脈炎:全球臨床實驗檢討 Giant Cell Arteritis Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月10日 內容資訊: 英文 70 Pages
簡介

本報告提供巨細胞動脈炎相關臨床研究的最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,地區、階段、phase別進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 巨細胞動脈炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管疾病臨床實驗上,巨細胞動脈炎所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心血管疾病臨床實驗上,巨細胞動脈炎所佔的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

未完成的臨床實驗數量 巨細胞動脈炎

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與巨細胞動脈炎治療藥臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Laboratorios Servier, S.L.
    • Janssen Global Services, LLC
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Oxford
    • Centre Hospitalier Universitaire Dijon
    • Japan Intractable Diseases Research Foundation
    • FDA Office of Orphan Products Development
    • 琦玉醫科大學
    • University of Bern
    • Caen University Hospital
    • University Hospital, Toulouse
    • University of Pennsylvania
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Giant Cell Arteritis Global Clinical Trials Review, H2, 2014" provides data on the Giant Cell Arteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Giant Cell Arteritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Giant Cell Arteritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Giant Cell Arteritis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Giant Cell Arteritis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Giant Cell Arteritis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Laboratorios Servier, S.L.
      • Clinical Trial Overview of Laboratorios Servier, S.L.
      • Janssen Global Services, LLC
      • Clinical Trial Overview of Janssen Global Services, LLC
    • Clinical Trial Overview of Top Institutes / Government
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Centre Hospitalier Universitaire Dijon
      • Clinical Trial Overview of Centre Hospitalier Universitaire Dijon
      • Japan Intractable Diseases Research Foundation
      • Clinical Trial Overview of Japan Intractable Diseases Research Foundation
      • FDA Office of Orphan Products Development
      • Clinical Trial Overview of FDA Office of Orphan Products Development
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • University of Bern
      • Clinical Trial Overview of University of Bern
      • Caen University Hospital
      • Clinical Trial Overview of Caen University Hospital
      • University Hospital, Toulouse
      • Clinical Trial Overview of University Hospital, Toulouse
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Giant Cell Arteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Giant Cell Arteritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Servier, S.L., 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire Dijon, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Intractable Diseases Research Foundation, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Caen University Hospital, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014*

List of Figures

  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Giant Cell Arteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Giant Cell Arteritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Giant Cell Arteritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top